基线代谢组学特征与卒中、痴呆发病及脑小血管病影像标志物的关联
该研究分析118,021名英国生物银行参与者的基线代谢组学特征,横断面评估325种代谢物与脑小血管病MRI标志物的关联,纵向评估其与卒中、痴呆发病的关联,并用孟德尔随机化推断因果关系。研究发现多种脂蛋白、脂肪酸等代谢物与白质微结构损伤、卒中及痴呆风险相关,部分关联有因果证据支持。
要点
- 极大型HDL的总脂质和HDL颗粒大小与白质损伤及全因卒中、缺血性卒中风险升高相关。
- 小HDL胆固醇水平与全因卒中和缺血性卒中风险降低相关,并有因果证据支持其与MRI确诊腔隙性卒中的关联。
- 缬氨酸与平均弥散率降低及全因痴呆风险降低相关。
核心结论
- 在这项大规模代谢组学研究中,发现多种代谢物与卒中、痴呆及脑小血管病MRI标志物相关。
- 进一步研究可能有助于个性化预测模型的开发,并为机制通路和未来治疗途径提供见解。
研究设计与样本
- 分析118,021名英国生物银行参与者的基线代谢组学特征。
- 横断面分析325种代谢物与脑小血管病MRI标志物的关联。
- 纵向评估代谢物与卒中、痴呆发病的关联。
- 使用孟德尔随机化判定因果关系。
主要发现
- 横断面分析中,载脂蛋白、游离胆固醇、胆固醇酯、脂肪酸、脂蛋白颗粒浓度、磷脂和甘油三酯水平较低与弥散张量MRI上白质微结构损伤增加相关。
- 纵向分析中,极大型高密度脂蛋白胆固醇(HDL)的脂蛋白亚类与卒中风险增加相关,乙酸和3-羟基丁酸与痴呆风险增加相关。
- 孟德尔随机化分析为许多发现提供了强有力的因果证据支持。
- 极大型HDL总脂质增加和HDL颗粒大小增加与白质损伤增加相关(各向异性分数降低:OR 1.44,95% CI 1.07-1.95;OR 1.19,95% CI 1.06-1.34;平均弥散率:OR 1.49,95% CI 1.11-2.01;OR 1.24,95% CI 1.11-1.40)及全因卒中风险增加相关(HR 4.04,95% CI 2.13-7.64;HR 1.54,95% CI 1.20-1.98)和缺血性卒中风险增加相关(HR 3.12,95% CI 1.53-6.38;HR 1.37,95% CI 1.04-1.81)。
- 缬氨酸与平均弥散率降低相关(OR 0.51,95% CI 0.30-0.88),并与全因痴呆呈保护性关联(HR 0.008,95% CI 0.002-0.035)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Cerebral small vessel disease is a major cause of stroke and dementia. Metabolomics can help identify novel risk factors to better understand pathogenesis and predict disease progression and severity. METHODS: We analyzed baseline metabolomic profiles from 118,021 UK Biobank participants. We examined cross-sectional associations of 325 metabolites with MRI markers of small vessel disease, evaluated longitudinal associations with incident stroke and dementia, and ascertained causal relationships using Mendelian randomization. RESULTS: In cross-sectional analyses, lower levels of apolipoproteins, free cholesterol, cholesteryl esters, fatty acids, lipoprotein particle concentrations, phospholipids, and triglycerides were associated with increased white matter microstructural damage on diffusion tensor MRI. In longitudinal analyses, lipoprotein subclasses of very large high-density lipoprotein cholesterol (HDL) were associated with an increased risk of stroke, and acetate and 3-hydroxybutyrate were associated with an increased risk of dementia. Mendelian randomization analyses identified strong evidence supporting causal relationships for many findings. A few metabolites had consistent associations across multiple analysis types. Increased total lipids in very large HDL and increased HDL particle size were associated with increased white matter damage (lower fractional anisotropy: OR: 1.44, 95% CI 1.07-1.95, and OR: 1.19, 95% CI 1.06-1.34, respectively; mean diffusivity: OR: 1.49, 95% CI 1.11-2.01, and OR: 1.24, 95% CI 1.11-1.40, respectively) and an increased risk of incident all stroke (HR: 4.04, 95% CI 2.13-7.64, and HR: 1.54, 95% CI 1.20-1.98, respectively) and ischemic stroke (HR: 3.12, 95% CI 1.53-6.38; HR: 1.37, 95% CI 1.04-1.81). Valine was associated with decreased mean diffusivity (OR: 0.51, 95% CI 0.30-0.88) and had a protective association with all-cause dementia (HR: 0.008, 95% CI 0.002-0.035). Increased levels of cholesterol in small HDL were associated with a decreased risk of incident all stroke (HR: 0.17, 95% CI 0.08-0.39) and ischemic stroke (HR: 0.19, 95% CI 0.08-0.46) and were supported by evidence of a causal association with MRI-confirmed lacunar stroke (OR: 0.96, 95% CI 0.93-0.99). DISCUSSION: In this large-scale metabolomics study, we found multiple metabolites associated with stroke, dementia, and MRI markers of small vessel disease. Further studies may help inform the development of personalized prediction models and provide insights into mechanistic pathways and future treatment approaches.
引用
- Harshfield EL, Markus HS. Association of Baseline Metabolomic Profiles With Incident Stroke and Dementia and With Imaging Markers of Cerebral Small Vessel Disease. Neurology. 2023. PMID: 37290969. doi:10.1212/WNL.0000000000207458
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。